Browse > Article

Inhibition of Cell Migration by Corticotropin-Releasing Hormone (CRH) in Human Natural Killer Cell Line, NK-92MI  

Cheon, So-Young (Department of Life Science, Sookmyung Women's University)
Bang, Sa-Ik (Department of Plastic Surgery, Samsung Medical Center, Sunhkyunkwan University School of Medicine)
Cho, Dae-Ho (Department of Life Science, Sookmyung Women's University)
Publication Information
IMMUNE NETWORK / v.5, no.4, 2005 , pp. 247-251 More about this Journal
Abstract
Background: Natural killer (NK) cells are CD3 (-) CD14 (-) CD56 (+) lymphocytes. They play an important role in the body's innate immune response. They can induce spontaneous killing of cancer cells or virus-infected cells via the Fas/Fas ligand or the granzyme/perforin systems. The corticotropin-releasing hormone (CRH) is an important regulator for the body's stress response. It promotes proliferation and migration of various cancer cells through the CRH type 1 receptor under stress, and also inhibits NK or T cell activity. However, the relationship of CRH and NK cell migration to the target has not been confirmed. Herein, we study the effect of CRH on NK cell migration. Methods: We used the human NK cell line, NK-92MI, and tested the expression of CRH receptor type 1 on NK-92MI by RT-PCR. This was to examine the effect of CRH on tumor and NK cell migration, thus NK cells (NK-92MI) were incubated with or without CRH and then each CRH treated cell's migration ability compared to that of the CRH untreated group. Results: We confirmed that CRH receptor type 1 is expressed in NK-92MI. CRH can decrease NK cell migration in a time-/dose-dependent manner. Conclusion: These data suggest CRH can inhibit NK cell migration to target cells.
Keywords
Corticotropin releasing hormone (CRH); NK cell; migration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Robertson MJ, Williams BT, Christopherson K 2nd, Brahmi Z, Hromas R: Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell Immunol 199;8-14, 2000   DOI   ScienceOn
2 Cheon SY, Daeho Cho: Enhancement of cell migration by corticotropin-releasing hormoen (CRH) in human gastric cancer cell line, MKN-28. Immune Network 4;224-249, 2004   DOI
3 Gismondi A, Jacobelli J, Strippoli R, Mainiero F, Soriani A, Cifaldi L, Piccoli M, Frati L, Santoni A: Proline-rich tyrosine kinase 2 and Rac activation by chemokine and intergrin receptors controls NK cell transendothelial migration. J Immunol 170;3065-3073, 2003   DOI   PUBMED
4 Roe SY, McGowan EM, Rothwell NJ: Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumtic brain injury. Eur J Neurosci 10;553-559, 1998   DOI   ScienceOn
5 Kim MH, Albertsson P, Xue Y, Kitson RP, Nannmark U, Goldfarb RH: Expression of matrix metalloproteinases and their inhibitor by rat NK cells: inhibition of their expression by genistein. In Vivo 14;557-564, 2000
6 Shibasaki T, Hotta M, Sugihara H, Wakabayashi I: Brain vasopressin is involved in stress-induced suppression of immune function in the rat. Brain Res 808;84-92, 1998   DOI   ScienceOn
7 Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA: A human CD34(+) subset resides lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22;295-304, 2005   DOI   ScienceOn
8 Ishida Y, Migita K, Izumi Y, Nakao K, Ida H, Kawakami A, Abiru S, Ishibashi H, Eguchi K, Ishii N: The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 569;156-160, 2004   DOI   PUBMED   ScienceOn
9 Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP: Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer'disease. Neurobiol Dis 8;492-503, 2001   DOI   ScienceOn
10 Franitza S, Grabovsky V, Wald O, Weiss I, Beider K, Dagan M, Darash-Yahana M, Nagler A, Brocke S, Galun E, Alon R, Peled A: Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interacton with endothelial cells. Eur J Immunol 34;1333-1341, 2004   DOI   ScienceOn
11 Hauger RL, Irwin MR, Lorang M, Auilra G, Brown MR: High intracerebral levels of CRH result in CRH receptor down-regulation in the amygdala and neuroimmune desensitization Brain Res 616;283-292, 1993   DOI   PUBMED   ScienceOn
12 Aguilera G, Rabadan-Diehl C, Nikodemova M: Regulation of pituitary corticotropin releasing hormone receptors. Peptides 22;769-774, 2001   DOI   ScienceOn
13 Hamerman JA, Ogasawara K, Lanier LL: NK cells in innate immunity. Curr Opin Immunol 17;29-35, 2005   DOI   ScienceOn
14 Russell JH, Ley TJ: Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20;323-370, 2002   DOI   ScienceOn
15 Albertsson P, Kim MH, Jonges LE, Kiston RP, Kuppen PJ, Johansson BR, Nannmark U Goldfarb RH: Matrix metal-loproteinasese of NK cells. In Vivo 14;269-276, 2000